Second, unlike other vaccine strategies that target dispensable tumor antigens, ALK positive lung cancers appear to be dependent on ALK signaling for cell survival, and genomic ALK rearrangements persist even after acquired resistance to ALK inhibitors emerges [6]. The gene discussed is ALK; the disease is neoplasm.